首页> 外文期刊>Nature reviews. Cardiology >Cardiovascular risk factors in patients with chronic kidney disease.
【24h】

Cardiovascular risk factors in patients with chronic kidney disease.

机译:慢性肾脏病患者的心血管危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with chronic kidney disease have a higher burden of cardiovascular disease, which increases in a dose-dependent fashion with worsening kidney function. Traditional cardiovascular risk factors, including advanced age, diabetes mellitus, hypertension and dyslipidemia, have an important role in the progression of cardiovascular disease in patients who have a reduced glomerular filtration rate, especially in those with mild-to-moderate kidney disease. In patients with severe kidney disease, nontraditional or 'novel' risk factors, including inflammation, oxidative stress, vascular calcification, a prothrombotic milieu, and anemia, seem to confer additional risk. In this Review, we highlight factors that increase cardiovascular risk in patients with a reduced estimated glomerular filtration rate. In addition, we discuss therapeutic strategies for reducing cardiovascular risk in patients with kidney disease, whose unique atherosclerotic phenotype might require an approach that differs from traditional models developed in populations with normal kidney function. Therapeutic paradigms for patients with chronic kidney disease and cardiovascular risk factors must be evaluated in randomized trials, from which such patients have often been excluded.
机译:慢性肾脏疾病患者的心血管疾病负担更高,随着肾脏功能的恶化,其呈剂量依赖性增加。传统的心血管疾病危险因素,包括高龄,糖尿病,高血压和血脂异常,在肾小球滤过率降低的患者(尤其是轻度至中度肾脏疾病患者)的心血管疾病进展中具有重要作用。在患有严重肾脏疾病的患者中,非传统的或“新的”危险因素,包括炎症,氧化应激,血管钙化,血栓形成的环境和贫血,似乎赋予了额外的危险。在本综述中,我们重点介绍了降低肾小球滤过率的患者增加心血管风险的因素。此外,我们讨论了降低肾脏疾病患者心血管风险的治疗策略,其独特的动脉粥样硬化表型可能需要的方法不同于在肾功能正常的人群中开发的传统模型。慢性肾脏病和心血管危险因素患者的治疗范例必须在随机试验中进行评估,而这类患者通常被排除在外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号